$Semler Scientific (SMLR.US)$🎯 On April 9, 2024, the curren...

New data: Q4 2023, revenue continues to grow, operating profit shrinks by 26.5% due to the decline in gross margin, and net income increases by 31.3% due to income tax refunds.

In 2023, revenue increased by 20.3%, operating profit increased by 33.6%, and net income increased by 43.7%. The average net profit growth rate since listing for 3 years is 13.7%.

The asset-liability ratio decreased from 11.2% to 8%, and both total assets and net assets have increased. On the asset side, cash and accounts receivable increased rapidly, while on the liability side, current liabilities decreased and there is no interest-bearing debt.

Currently, the PE ratio is 11, and the growth rate discount is significant. Considering that the current revenue scale is still small, it is advisable to choose cautiously (⭐️).